Susquehanna Fundamental Investments, LLC Can Fite Bio Pharma Ltd. Transaction History

Susquehanna Fundamental Investments, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2021 May 17, 2021	SELL	$1.8 - $2.92 $31,140 - $50,516	-17,300 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$1.61 - $2.67 $27,853 - $46,191	17,300 New	17,300 $31,000

1.1K

Ticker CANF
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,191,500
Market Cap $40.2M
Description
Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction. The company's lead drug candidate Piclidenoson, which has been completed Phase III clinical trial for the treatment of psoriasis; and Phase II clinic...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.